Page last updated: 2024-11-06

mitomycin and Corneal Dystrophy, Juvenile Epithelial of Meesmann

mitomycin has been researched along with Corneal Dystrophy, Juvenile Epithelial of Meesmann in 2 studies

Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.

Corneal Dystrophy, Juvenile Epithelial of Meesmann: An autosomal dominant form of hereditary corneal dystrophy due to a defect in cornea-specific KERATIN formation. Mutations in the genes that encode KERATIN-3 and KERATIN-12 have been linked to this disorder.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ghanem, RC1
Piccinini, AL1
Ghanem, VC1
Yeung, JY1
Hodge, WG1

Other Studies

2 other studies available for mitomycin and Corneal Dystrophy, Juvenile Epithelial of Meesmann

ArticleYear
Photorefractive Keratectomy With Mitomycin C in Meesmann's Epithelial Corneal Dystrophy.
    Journal of refractive surgery (Thorofare, N.J. : 1995), 2017, Jan-01, Volume: 33, Issue:1

    Topics: Adult; Alkylating Agents; Combined Modality Therapy; Corneal Dystrophy, Juvenile Epithelial of Meesm

2017
Recurrent Meesmann's corneal dystrophy: treatment with keratectomy and mitomycin C.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2009, Volume: 44, Issue:1

    Topics: Adult; Alkylating Agents; Combined Modality Therapy; Corneal Dystrophy, Juvenile Epithelial of Meesm

2009